Cargando…
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients
INTRODUCTION: The efficacy of taurolidine containing lock solutions for the prevention of central line-associated bloodstream infections (CLABSI) in paediatric oncology patients is still unknown. If the taurolidine-citrate-heparin lock appears to decrease the incidence of CLABSIs, we hope to increas...
Autores principales: | van den Bosch, Ceder Hildegard, Loeffen, Yvette, van der Steeg, Alida F W, van der Bruggen, Jan-Tom T, Frakking, Florine N J, Fiocco, Marta, van de Ven, Cornelis P, Wijnen, Marc H W A, van de Wetering, Marianne D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032404/ https://www.ncbi.nlm.nih.gov/pubmed/36944461 http://dx.doi.org/10.1136/bmjopen-2022-069760 |
Ejemplares similares
-
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients
por: Reidenberg, Bruce E., et al.
Publicado: (2017) -
Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
por: Olthof, Evelyn D., et al.
Publicado: (2014) -
Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011) -
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017) -
Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)